Search clinical trials for: nateglinide

Total 20 results

Novartis Pharmaceuticals

Completed

Long-term Study of Nateglinide+Valsartan to Prevent or Delay Type II Diabetes Mellitus and Cardiovascular Complications (Navigator)

Diabetes Mellitus, Type 2

Austria, Argentina, Australia, Belgium, Brazil, Canada, Chile, China, Colombia, Denmark, Ecuador, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Italy, Malaysia, Mexico, Netherlands, Norway, Peru, Poland, Russian Federation and more
Astellas Pharma Inc

Completed

A Study to Assess Safety and Efficacy of ASP1941 in Combination With Nateglinide in Type 2 Diabetic Patients

Type 2 Diabetes Mellitus

Japan
Atheline Major-Pedersen
Bayer; Novartis

Completed

Insulin Resistance and Vessel Function After Meals: Does Early Intervention Make a Difference?

Insulin Resistance | Impaired Fasting Glucose

Denmark
Ajou University School of Medicine
Korea University Guro Hospital; Hanyang University; Bundang CHA Hospital; Hallym... and other collaborators

Completed

Study of the Durability of Glycemic Control With Nateglinide

Type 2 Diabetes Mellitus

Korea, Republic of
Novartis Pharmaceuticals

Completed

Safety and Efficacy of Nateglinide in Patients With Type 2 Diabetes Already Taking Insulin Glargine, Metformin and/or Pioglitazone or Rosiglitazone

Type 2 Diabetes

United States
Canadian Network for Observational Drug Effect...
Canadian Institutes of Health Research (CIHR); Drug Safety and Effectiveness...

Completed

Incretin-based Drugs and Acute Pancreatitis

Diabetes Mellitus, Type 2

Canada
Canadian Network for Observational Drug Effect...
Canadian Institutes of Health Research (CIHR); Drug Safety and Effectiveness...

Completed

Incretin-based Drugs and the Risk of Heart Failure

Type 2 Diabetes Mellitus

Canada
Canadian Network for Observational Drug Effect...
Canadian Institutes of Health Research (CIHR); Drug Safety and Effectiveness...

Completed

Incretin-based Drugs and Pancreatic Cancer

Diabetes Mellitus, Type 2

Canada
IlDong Pharmaceutical Co Ltd

Completed

A Open-label, Single-dose, 2-Sequence, 2-Period, Crossover Study to Assess Safety and Pharmacokinetics of a Nateglinide/Metformin HCl Combined Tablet Compared With a Nateglinide 120 mg Tablet and Metformin HCl 500 mg Tablet Under Fasting Conditions in Healthy Male Subjects

Healthy Volunteers

Korea, Republic of
Novartis Pharmaceuticals

Completed

Effects of Nateglinide on Postprandial Glucose Excursion by Restoring Early Phase Insulin Secretion

Diabetes Mellitus, Type 2

China
Novartis Pharmaceuticals

Completed

Effects of Nateglinide vs Acarbose on Postprandial Glucose Fluctuation, Dyslipidemia, and Inflammatory Factors (ENERGY)

Diabetes Mellitus, Type 2

China
Novartis Pharmaceuticals

Completed

A Pilot Study to Evaluate the Effects of Nateglinide vs. Glibenclamide on Renal Hemodynamics and Albumin Excretion

Diabetes Mellitus, Type 2
Dr. Reddy's Laboratories Limited

Completed

Bioequivalence Study of Nateglinide Tablets 120 mg of Dr. Reddy's Laboratories Limited Under Fed Condition

Healthy
Dr. Reddy's Laboratories Limited

Completed

Bioequivalence Study of Nateglinide Tablets 120 mg of Dr. Reddy's Laboratories Limited Under Fasting Condition

Healthy
National Institute of Diabetes and Digestive and...

Completed

Insulin Resistance and Central Nervous System (CNS) Function in Type 2 Diabetes

Type 2 Diabetes Mellitus | Insulin Resistance

United States
Keio University

Completed

Combination of Glinides With Premixed Insulin

Type 2 Diabets Mellitus

Japan
Kissei Pharmaceutical Co., Ltd.

Completed

Double-Blind Comparison Between Mitiglinide and Nateglinide in Type 2 Diabetic Patients

Diabetes
Inje University
Sanofi

Completed

The Effects of Nateglinide and Acarbose on the Post-Prandial Glucose Control in Type 2 Diabetic Patients

Diabetes Mellitus | Type 2 Diabetes Mellitus

Korea, Republic of
Astellas Pharma Inc
Ajinomoto USA, INC.

Completed

Nateglinide: a Double Blind Add-on Study With Pioglitazone for Type 2 Diabetic Patients

Type 2 Diabetes Mellitus | Diabetes Mellitus, Type II

Japan
University of Oslo School of Pharmacy

Completed

Efficacy and Safety of Nateglinide Treatment in Renal Transplant Recipients

Renal Transplant Recipients | Posttransplant Diabetes Mellitus | Posttransplant Impaired Glucose Tolerance

Norway

Search clinical trials for: nateglinide

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Macedonia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations